XML 50 R38.htm IDEA: XBRL DOCUMENT v3.21.2
ACQUISITIONS AND OTHER ARRANGEMENTS - Additional Information (Details)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended
Jul. 29, 2021
USD ($)
Mar. 31, 2021
USD ($)
Feb. 28, 2021
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Business Acquisition [Line Items]              
Payments to acquire productive assets           $ 329 $ 316
Net sales       $ 3,098 $ 2,718 6,044 $ 5,520
PerClot | Subsequent Event              
Business Acquisition [Line Items]              
Contingent consideration, fair value $ 25            
Contingent Consideration $ 36            
Caelyx and Doxil              
Business Acquisition [Line Items]              
Payments to acquire productive assets     $ 325        
Net sales       $ 28   $ 41  
Caelyx and Doxil | Customer Relationships              
Business Acquisition [Line Items]              
Weighted-average useful life     8 years        
Payments to acquire productive assets     $ 11        
Caelyx and Doxil | Developed Technology Intangible Asset              
Business Acquisition [Line Items]              
Weighted-average useful life     9 years        
Payments to acquire productive assets     $ 314        
Transderm Scop | Glaxo Smith Kline              
Business Acquisition [Line Items]              
Cash   $ 60          
Contingent consideration, fair value   24          
Contingent Consideration   30          
Transderm Scop | Developed Product Rights | Glaxo Smith Kline              
Business Acquisition [Line Items]              
Fair value of asset acquired   $ 64          
Weighted-average useful life   9 years          
Transderm Scop | Developed Product Rights | Measurement Input, Discount Rate | Glaxo Smith Kline              
Business Acquisition [Line Items]              
Discount rate used to measure intangible assets   0.225          
Transderm Scop | Customer Relationships | Glaxo Smith Kline              
Business Acquisition [Line Items]              
Fair value of asset acquired   $ 3          
Weighted-average useful life   7 years          
Transderm Scop | Customer Relationships | Measurement Input, Discount Rate | Glaxo Smith Kline              
Business Acquisition [Line Items]              
Discount rate used to measure intangible assets   0.155